Recently, however, the discovery of molecules responsible for the pathogenesis of cancer has led to the introduction of targeted pharmacotherapies to SEGA treatment aimed at inhibiting various kinases and signaling pathways, including mTOR kinase [3,36,81,83,94,95,96,97,98]. This evidence concerns the gene MTOR and cancer.